amphetamine has been researched along with Tremor in 25 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cyclizine was observed to induce generalized chorea in a patient with mild lingual-facial-buccal dyskinesias." | 7.65 | Cyclizine-induced chorea. Observations on the influence of cyclizine on dopamine-related movement disorders. ( Klawans, HL; Moskovitz, C, 1977) |
| "Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine." | 6.64 | Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. ( Fenton, GW; Parkes, JD, 1973) |
| " When an animal moves on the plate, its movements are sensed by the transducers whose signals are processed by computer to yield measurements of a wide range of behaviors or behavioral attributes, such as locomotor activity, rotation around the center, whole-body tremor, and amphetamine-induced stereotypies." | 3.71 | A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. ( Birkestrand, BR; Chen, R; Fowler, SC; Moss, SJ; Vorontsova, E; Wang, G; Zarcone, TJ, 2001) |
| " Because prenylated proteins are avid methyl acceptors at the terminal carboxylic acid groups, 1 micromol S-farnesylcysteine (FC) analogs blocked the SAM-induced tremors in the experimental rats." | 3.70 | Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats. ( Charlton, CG; Lamango, NS, 2000) |
| "Cyclizine was observed to induce generalized chorea in a patient with mild lingual-facial-buccal dyskinesias." | 3.65 | Cyclizine-induced chorea. Observations on the influence of cyclizine on dopamine-related movement disorders. ( Klawans, HL; Moskovitz, C, 1977) |
| " Tremors induced by chemical agents (nicotine, zinc and tremorine) were markedly inhibited by HA-966." | 3.65 | 1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases. ( Bonta, IL; De Vos, CJ; Grijsen, H; Hillen, FC; Noach, EL; Sim, AW, 1971) |
| " Carbachol or oxotremorine injected in small doses intracerebroventricularly into conscious mice caused hypothermia, gross tremor and a variety of parasympathomimetic effects including lachrymation and salivation." | 3.65 | Investigation of central cholinergic mechanisms in the conscious mouse. ( Ankier, SI; Brittain, RT; Jack, D, 1971) |
| " Dextroamphetamine in lower dosage also reduced disability by some 17 percent." | 2.64 | Amphetamines in the treatment of Parkinson's disease. ( Asselman, P; Bovill, KT; Marsden, CD; Parkes, JD; Phipps, JA; Rose, P; Tarsy, D, 1975) |
| "Cataplexy was not affected by amphetamine treatment, but was abolished in two patients when clomipramine was given together with either amphetamine." | 2.64 | Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. ( Fenton, GW; Parkes, JD, 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (84.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 1 (4.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Downey, LA | 1 |
| Tysse, B | 1 |
| Ford, TC | 1 |
| Samuels, AC | 1 |
| Wilson, RP | 1 |
| Parrott, AC | 1 |
| DE LA VIGNE ROUAULT, A | 1 |
| THEOBALD, W | 1 |
| BUECH, O | 1 |
| KUNZ, HA | 1 |
| MORPURGO, C | 1 |
| STENGER, EG | 1 |
| WILHELMI, G | 1 |
| Björkman, S | 1 |
| Lewander, T | 1 |
| Zetterström, T | 1 |
| Lamango, NS | 1 |
| Charlton, CG | 1 |
| Fowler, SC | 1 |
| Birkestrand, BR | 1 |
| Chen, R | 1 |
| Moss, SJ | 1 |
| Vorontsova, E | 1 |
| Wang, G | 1 |
| Zarcone, TJ | 1 |
| Klawans, HL | 1 |
| Moskovitz, C | 1 |
| Parkes, JD | 2 |
| Tarsy, D | 1 |
| Marsden, CD | 1 |
| Bovill, KT | 1 |
| Phipps, JA | 1 |
| Rose, P | 1 |
| Asselman, P | 1 |
| Ghosal, S | 1 |
| Sharma, PV | 1 |
| Chaudhuri, RK | 1 |
| Bhattacharya, SK | 1 |
| Ketema, H | 1 |
| Davis, WM | 1 |
| Walker, LA | 1 |
| Borne, RF | 1 |
| Stern, P | 1 |
| Jefferson, JW | 1 |
| Poirier, LJ | 1 |
| Langelier, P | 1 |
| Bédard, P | 1 |
| Boucher, R | 1 |
| Larochelle, L | 1 |
| Parent, A | 1 |
| Roberge, AG | 1 |
| Birkmayer, W | 1 |
| Gumulka, W | 1 |
| Kostowski, W | 1 |
| Czlonkowski, A | 1 |
| Fenton, GW | 1 |
| Wolf, HH | 1 |
| Rollins, DE | 1 |
| Rowland, CR | 1 |
| Reigle, TG | 1 |
| Smith, RP | 1 |
| Laville, C | 1 |
| Margarit, J | 1 |
| Frances, H | 1 |
| Jacob, J | 1 |
| Bonta, IL | 1 |
| De Vos, CJ | 1 |
| Grijsen, H | 1 |
| Hillen, FC | 1 |
| Noach, EL | 1 |
| Sim, AW | 1 |
| Chiang, TS | 1 |
| Leaders, FE | 1 |
| Ankier, SI | 1 |
| Brittain, RT | 1 |
| Jack, D | 1 |
| Hammer, W | 1 |
| Karlén, B | 1 |
| Sjöqvist, F | 1 |
| Otis, LS | 1 |
| Willis, JA | 1 |
| Pryor, GT | 1 |
1 review available for amphetamine and Tremor
| Article | Year |
|---|---|
Beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alcoholism; Amphetamine; Animals; Antidepressive Agents; | 1974 |
4 trials available for amphetamine and Tremor
| Article | Year |
|---|---|
Amphetamines in the treatment of Parkinson's disease.
Topics: Aged; Amantadine; Amphetamine; Clinical Trials as Topic; Female; Humans; Isomerism; Levodopa; Male; | 1975 |
Beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alcoholism; Amphetamine; Animals; Antidepressive Agents; | 1974 |
[10 years of L-DOPA therapy of Parkinson's syndrome].
Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topi | 1971 |
Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy.
Topics: Adult; Amphetamine; Antidepressive Agents; Cataplexy; Dextroamphetamine; Electroencephalography; Eva | 1973 |
21 other studies available for amphetamine and Tremor
| Article | Year |
|---|---|
Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants.
Topics: Accelerometry; Adult; Amphetamine; Arm; Central Nervous System Stimulants; Drug Users; Female; Human | 2017 |
[Therapy of a hysterical tremor by synthetic curare shock].
Topics: Amphetamine; Amphetamines; Convulsive Therapy; Curare; Muscle Relaxants, Central; Shock; Tremor | 1953 |
[COMPARATIVE PHARMACOLOGICAL INVESTIGATIONS WITH TOFRANIL, PERTOFRAN AND INSIDON].
Topics: Acetylcholine; Amphetamine; Amphetamines; Anesthetics; Animals; Antidepressive Agents; Catatonia; Ca | 1964 |
MIF (Pro-Leu-Gly-NH2): failure to affect oxotremorine effects in mice and rats as well as fluphenazine catalepsy or amphetamine hyperactivity in rats.
Topics: Amphetamine; Animals; Catalepsy; Fluphenazine; Humans; Male; Mice; Motor Activity; MSH Release-Inhib | 1980 |
Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Chromatography, Gel; Cysteine; Freeze Dryin | 2000 |
A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor.
Topics: Amphetamine; Animals; Behavior, Animal; Biomechanical Phenomena; Central Nervous System; Dopamine Up | 2001 |
Cyclizine-induced chorea. Observations on the influence of cyclizine on dopamine-related movement disorders.
Topics: Aged; Amphetamine; Animals; Apomorphine; Behavior, Animal; Chorea; Cyclizine; Dyskinesia, Drug-Induc | 1977 |
Chemical constituents of gentianaceae XIV: tetraoxygenated and pentaoxygenated xanthones of Swertia purpurascens Wall.
Topics: Amphetamine; Animals; Chromatography, Thin Layer; Dogs; Drug Synergism; Ethers; Flavonoids; Hexobarb | 1975 |
Pharmacologic and toxicologic effects of di(beta-phenylisopropyl)amine (DPIA) in rats and mice.
Topics: Amphetamine; Animals; Antidotes; Blood Pressure; Eating; Heart Rate; Hemodynamics; Lethal Dose 50; M | 1990 |
The influence of synthetic "substance P" on tremor caused by LSD in mice.
Topics: Acetylcholine; Amphetamine; Animals; Atropine; Behavior, Animal; Brain Chemistry; Drug Synergism; Fe | 1973 |
Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
Topics: Acetylcholine; Amphetamine; Animals; Cats; Corpus Striatum; Disease Models, Animal; Dopamine; Fronta | 1974 |
Role of 5-HT in the action of some drugs affecting extrapyramidal system.
Topics: Amphetamine; Animals; Brain; Catalepsy; Chlorpromazine; Electrodes; Extrapyramidal Tracts; Female; F | 1973 |
The importance of endogenous catecholamines in the activity of some CNS stimulants.
Topics: Amphetamine; Animals; Antidepressive Agents; Catecholamines; Central Nervous System; Ephedrine; Male | 1969 |
Cyanate and thiocyanate: acute toxicity.
Topics: Amphetamine; Animals; Antidotes; Arginine; Cyanates; Female; Methemoglobin; Mice; Morphine; Oxyhemog | 1973 |
[The effects of sulpiride on the central nervous system].
Topics: Amphetamine; Analgesia; Animals; Atropine; Chlorpromazine; Male; Mescaline; Mice; Morphine; Nicotine | 1969 |
[Comparison of the effects of cholinergic and anticholinergic substances on the cerebral content of acetylcholine and on the motility of mice].
Topics: Acetylcholine; Amphetamine; Animals; Atropine; Benactyzine; Brain Chemistry; Glycolates; Imipramine; | 1971 |
1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.
Topics: Acoustic Stimulation; Amines; Amphetamine; Animals; Basal Ganglia Diseases; Behavior, Animal; Brain | 1971 |
Antagonism of aceclidine-induced tremor, analgesia, hypothermia, salivation and lacrimation by some pharmacologic agents.
Topics: Amphetamine; Animals; Atropine; Central Nervous System; Diphenhydramine; Drug Antagonism; Female; Hy | 1971 |
Investigation of central cholinergic mechanisms in the conscious mouse.
Topics: Acetylcholine; Amphetamine; Animals; Antidepressive Agents; Atropine; Brain; Carbachol; Cerebral Ven | 1971 |
Drug-induced changes in brain levels of oxotremorine in mice.
Topics: Amphetamine; Animals; Atropine; Binding Sites; Brain Chemistry; Hypothermia, Induced; Male; Metaboli | 1968 |
Tremor detector for the mouse.
Topics: Amphetamine; Animals; Electronics; Mice; Tremor; Tremorine | 1969 |